En Es
Categories

Industry News

Fujifilm and IU School of Medicine to Study AI in Diagnostic Imaging

By Medimaging International staff writers
12 Sep 2018

Image: Researchers are working to develop the application of AI in medical imaging diagnostics (Photo courtesy of Digital Health).Fujifilm Corporation (Tokyo, Japan) has entered into a joint research agreement with Indiana University School of Medicine (Indianapolis, IN, USA) to develop the application of artificial intelligence (AI) in medical imaging diagnostic support systems.

Going forward, as clinical information is increasingly viewed in the context of big data, AI technology will be applied to develop products that meet the different and challenging needs of the healthcare industry. For instance, recent technological advancements in diagnostic imaging system capabilities, such as multi-slice CT, have created the need for an efficient solution to read and interpret the increased number of images being generated. The application of AI technology to support physicians by detecting suspicious lesions in images, comparing results with prior studies and the implementation of semi-automated reporting is expected to significantly increase the efficiency of diagnostic medical imaging in patient care.

Fujifilm is using AI technology to develop image diagnosis support systems, which will support the overall diagnostic workflow of physicians. In addition to undertaking various in-house development projects, Fujifilm is also entering into a partnership with leading AI technology vendors to expand the disease coverage of its systems. The Indiana University School of Medicine is affiliated with Indiana University Health (IU Health), a medical healthcare system with 17 hospitals and about 33,000 employees in the US.

The collaboration aims to combine Fujifilm’s image processing and AI technology with the Indiana University School of Medicine’s rich diagnostic and clinical expertise to develop medical AI technology, while searching for a system optimized to support diagnosis workflow. The research will initially utilize Fujifilm’s AI technology to segment and quantify muscle atrophy (sarcopenia) in body images, as well as detect and quantify brain lesions in neuroradiology imaging exams.



E-mail Print
FaceBook Twitter Google+ Linked in

Fujifilm

Offers diagnostic imaging products, including FCR” digital x-ray imaging and diagnostic systems, “Synapse” medical-use picture archiving and communications systems (PACS), dry imaging films/dry imagers, X-ray films, radiopharmaceuticals, digital endoscopes, nucleic acid isolation systems, healthcare products and pharmaceutical
More info

More articles about Fujifilm

24 Dec 2019
Fujifilm to Acquire Hitachi’s Diagnostic Imaging-related Business
 FUJIFILM Corporation (Tokyo, Japan) has entered into an agreement with Hitachi, Ltd. (Tokyo, Japan) to acquire its Diagnostic Imaging-related business to further expand its Healthcare business. By applying its proprietary image processing and artificial intelligence (AI) technologies to Hitachi’s extensive product lineup, Fujifilm aims to further expand its Medical Systems business and create new values to contribute to improve the quality of medical care.
Read More
24 Apr 2018
Fujifilm Showcases Extended Product Line at ECR 2018
Fujifilm Medical Systems Europe, a provider of diagnostic imaging products and medical informatics solutions, showcased its broad, enhanced line up of products and solutions at the European Congress of Radiology (ECR) 2018. The products and solutions showcased by Fujifilm at ECR 2018 focused on women’s health, healthcare IT, artificial intelligence (AI), digital radiography (DR), computed tomography (CT), computed radiography and ultrasound.
Read More

Additional news

21 Apr 2021
FDA Clears First-Ever AI Mammography Triage Software that Supports both 3D and 2D Mammography
The US Food and Drug Administration has cleared the first-ever artificial intelligence (AI) mammography triage software that supports both 3D and 2D mammography.
Read More
20 Apr 2021
Global Digital PCR and Real-Time PCR Market Growth Driven by Increasing Cases of Infectious Diseases
Increasing cases of infectious diseases, rising geriatric population and growing number of genetic disorders will propel the growth of the global digital PCR and real-time PCR market over the next decade. Additionally, PCR advances, fulfillment of the human genome project, and expanding R&D will increase the utilization of biomarker profiling for sickness diagnostics, thus further driving market growth.
Read More
19 Apr 2021
Siemens Completes Acquisition of Varian to Create Integrated Portfolio of Imaging, Laboratory Diagnostics, AI and Cancer Treatment
Siemens Healthineers (Erlangen, Germany) has successfully completed the acquisition of Varian Medical Systems, Inc. (Palo Alto, CA, USA), thus strengthening its position as a holistic partner in healthcare.
Read More
16 Apr 2021
Eppendorf Introduces Multipurpose Centrifuge 5910 Ri to Accelerate Results
Eppendorf AG (Hamburg, Germany) has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri, a successor to the company’s popular Centrifuge 5910 R.
Read More
16 Apr 2021
Artificial Intelligence (AI) in Medical Diagnostics Market to Reach USD 3.86 Billion by 2025
The global Artificial Intelligence (AI) in Medical Diagnostics Market is projected to grow at a CAGR of 50.2% from USD 0.5 billion in 2020 to USD 3.86 billion by 2025, driven primarily by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field, growing focus on reducing the workload of radiologists, influx of large and complex datasets, growth in funding for AI-based start-ups, and growing number of cross-industry partnerships and collaborations.
Read More
15 Apr 2021
Microsoft Acquires Radiology Vendor Nuance to Deliver New Cloud and AI Capabilities Across Healthcare
Microsoft Corporation (Redmond, WA, USA) will acquire Nuance Communications, Inc. (Burlington, MA, USA) in an all-cash transaction valued at USD 19.7 billion to combine their solutions and expertise that will deliver new cloud and AI capabilities across healthcare and other industries.
Read More
14 Apr 2021
Zoll Medical Acquires CSA Systems Manufacturer Respicardia
 ZOLL Medical Corporation (Chelmsford, MA, USA), an Asahi Kasei company, has acquired Respicardia, Inc. (Minnetonka, MN, USA), a provider of novel implantable neurostimulators for the treatment of moderate to severe Central Sleep Apnea (CSA).
Read More
13 Apr 2021
DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space
DiaSorin S.p.A. (?Saluggia?, Italy) has announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (Austin, TX, USA) for approximately USD 1.8 billion.
Read More
13 Apr 2021
Philips Collaborates with AI Startup Ibex to Accelerate Adoption of AI-Powered Digital Pathology Solutions
Royal Philips (Amsterdam, The Netherlands) and Ibex Medical Analytics (Tel Aviv, Israel) have entered into a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions